CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Other acquisition Director acquired 1,618 shares (other)
- 4 Other acquisition Director acquired 1,618 shares (other)
- 4 Other acquisition Director acquired 920 shares (other)
- 4 Other acquisition Director acquired 920 shares (other)
- 4 Other acquisition Director acquired 866 shares (other)
- 4 Other acquisition Director acquired 866 shares (other)
- 4 Open-market buy Exec. Vice Chairman/CEO/Pres. bought 2,632 shares at $4.37 ($11,502)
- 4/A Open-market buy Exec. Vice Chairman/CEO/Pres. bought 29,404 shares at $4.03 ($118,498)
- 4 Open-market buy Chief Science/Medical Officer bought 2,481 shares at $4.03 ($9,998)
- 4 Open-market buy Dir Govt Relations/Sectry bought 8,695 shares at $4.03 ($35,041)
- 4 Open-market buy Director bought 9,677 shares at $4.03 ($38,998)
- 4 Open-market buy Sr. VP of Operations bought 5,211 shares at $4.03 ($21,000)
- 4 Open-market buy Director bought 9,677 shares at $4.03 ($38,998)
- 4 Open-market buy Exec. Vice Chairman/CEO/Pres. bought 29,404 shares at $4.03 ($118,498)
- 4 Other acquisition Director acquired 711 shares (other)
- 4 Other acquisition Director acquired 711 shares (other)
- 4 Conversion Director acquired 340,000 shares (conversion)
- 4 Conversion Director acquired 340,000 shares (conversion)
- 4 Conversion Sr. VP of Operations acquired 85,000 shares (conversion)
- 4 Conversion Dir Govt Relations/Sectry acquired 153,000 shares (conversion)
Page 9 of 31 · 615 filings